Publications

24 résultats Voir en premier : les plus pertinents | les plus récents
    • Maladies, Politique internationale
    • 2009
    • Rapport
    • Français, Allemand, Anglais

    Le présent rapport traite du lot 5 d’EuroHeart et présente les stratégies et actions nationales dans le domaine de la promotion de la santé cardiovasculaire et de la prévention des maladies cardiovasculaires dans 16 pays d’Europe. Le rapport et ses conclusions seront largement diffusés auprès des décideurs européens pour leur permettre d’analyser leur stratégie nationale à la lumière des actions entreprises dans les autres pays. Le rapport offre un instantané de la situation. S’attaquer aux MCV n’est pas un processus statique. C’est pourquoi il est essentiel d’analyser et d’évaluer en continu l’impact des stratégies en place. Le Réseau européen du coeur est convaincu que même si la politique de santé relève largement du domaine des États membres de l’UE, l’UE peut les accompagner et participer à la réduction des inégalités au sein des pays et entre les pays, par exemple, en établissant des comparatifs à partir de recommandations communes. En termes de place de la santé cardiaque dans les autres politiques, l’UE peut indéniablement jouer un rôle majeur en assurant une évaluation efficace de l’impact sur la santé des mesures proposées dans un large éventail de politiques.

    • Date de parution:
    • Editeur: European Heart Network (EHN)
    • Politique internationale, Maladies
    • 2012
    • Rapport
    • Anglais

    [Rapport 2012 sur l’état de l’art des activités relatives aux maladies rares en Europe - Partie I: Aperçu des activités sur les maladies rares en Europe ]
    This document was produced by the Scientific Secretariat of the European Union Committee of Experts on Rare Diseases (EUCERD), through the EUCERD Joint Action: Working for Rare Diseases (N° 2011 22 01), which covers a three year period (March 2012 – February 2015).
    The present report aims to provide an informative and descriptive overview of rare disease activities at European Union (EU) and Member State (MS) level in the field of rare diseases and orphan medicinal products up to the end of 2011. A range of stakeholders in each Member State/country have been consulted during the elaboration of the report, which has been validated as an accurate representation of activities at national level, to the best of their knowledge, by the Member State/country representatives of the European Union Committee of Experts on Rare Diseases. The reader, however, should bear in mind that the information provided is not exhaustive and is not an official position of either the European Commission, its Agencies or national health authorities.
    The report is split into five parts available on the EURCED website

    • Part I: Overview of rare disease activities in Europe
    • Part II: Key developments in the field of rare diseases in 2011
    • Part III: European Commission activities in the field of rare diseases
    • Part IV: European Medicines Agency activities and other European activities in the field of rare diseases
    • Part V: Activities in EU Member States and other European countries in the field of rare diseases
    Each part contains the following description of the methodology, sources and validation process of the entire report, and concludes with a selected bibliography and list of persons having contributed to the report.

    • Date de parution:
    • Editeur: European Union Committee of Experts on Rare Diseases (EUCERD)
    • Santé sexuelle, Maladies, Politique internationale
    • Rapport
    • Anglais

    [Plan d'action européen contre le VIH / SIDA 2012-2015]
    The primary audience for the European Action Plan for HIV/AIDS 2012–2015 is the national authorities in the WHO European Region responsible for HIV diagnosis, prevention, treatment, care and support, including health ministries and other government bodies responsible for health.
    The Action Plan is also intended for national authorities and ministries other than those directly responsible for health, including finance, education, social welfare, child protection, transportation, infrastructure, criminal justice, labour, immigration, development, defence, and foreign affairs, as well as associations, professional bodies, researchers, academics, civil society, advocacy groups, trade unions, the private sector, and international and global partners, including bilateral and multilateral donors.

    • Date de parution:
    • Editeur: Organisation Mondiale de la Santé (OMS) [World Health Organization (WHO)]
    • Maladies, Politique internationale
    • 2010
    • Ouvrage
    • Anglais

    [Lignes directrices européennes pour l'assurance de la qualité dans le dépistage du cancer colorectal]

    The guidelines on colorectal cancer screening form the third and final set of three cancer screening guidelines on breast and cervical cancer published by the Commission to assist Member States in their screening and early detection programmes.

    Today’s publication provides the first ever set of uniform guidelines on all the steps necessary for effective population based colorectal cancer screening in the EU. By implementing them, Member States have the potential to organise their health systems more effectively, including the diagnosis and management of cancers detected in screening. There is good evidence that population-based screening using the EU-recommended test reduces mortality from colorectal cancer by around 15% in people of appropriate age (50 to 74 years) invited to attend screening.

    The guidelines, coordinated for the Commission by the International Agency for Research on Cancer (IARC), were developed with the input of over 90 experts from 32 countries, and set a benchmark for best practice in colorectal cancer screening. Widespread application of the Guidelines should also make it easier for experts in the field to exchange information and experience across the EU. This is essential for innovation and continuous quality improvement of existing cancer screening programmes.

    • Date de parution:
    • Editeur: Publications Office of the European Union
  • Dernière modification le 12-10-2015